enesfr de SE

Evidencia científica

617 artículos revisados por expertos publicados hasta ahora

2023
Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update

https://www.frontiersin.org/journals/gastroenterology/articles/10.3389/fgstr.2022.1022530/full

alternative / anti-TNFα / biologics / complementary / gma / IBD / Jak inhibitors /
Continúa
2023
PP0916 COMBINATION OF GRANULOCYTE–MONOCYTE APHERESIS AND TOFACITINIB: MULTICENTRE AND RETROSPECTIVE STUDY

UEG Week 2023 Poster Presentations – 2023 – United European Gastroenterology Journal – Wiley Online Library

biologic exposed / combination / fecal calprotectin / gma / lor / Multicenter / PCR / pnr / refractory / RETROSPECTIVE / Steroid free / study / tofacitinib / ulcerative colitis /
Continúa
2023
PP0882 EFFICACY AND SAFETY OF GRANULOCYTOAPHERESIS IN THE TREATMENT OF STEROID-DEPENDENT AND STEROID-REFRACTORY INFLAMMATORY BOWEL DISEASE

UEG Week 2023 Poster Presentations – 2023 – United European Gastroenterology Journal – Wiley Online Library

biologic exposed / calprotectin / colonic mucosa / efficacy / gma / IBD / PCR / retrsopective / RWE / Safety / steroid dependent / steroid refractory /
Continúa
2023
PP0485 NEW INSIGHTS INTO THE MECHANISM OF ACTION OFGRANULOCYTE-MONOCYTE APHERESIS REVEALED BY SINGLE-CELL TRANSCRIPTOMIC ANALYSIS

UEG Week 2023 Poster Presentations – 2023 – United European Gastroenterology Journal – Wiley Online Library

CD14+ / gma / IGHE / IGHEP1 / immunology / innate immunity / LINC02315 / MAPK / MOA / monocytes / NEFL / pheripheral blood / single-cell / transcriptomics / ulcerative colitis /
Continúa
2023
Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis (UC): evidence from a systematic literature review (SLR)

https://link.springer.com/article/10.1007/s00535-023-02048-w

ASUC / Clinical remission / cohort / cyclosporine / efficacy / gma / golimumab / Infliximab / moderate to severe / Multicenter / observational / Safety / steoids / study / systematic literature review / Tacrolimus / tofacitinib / ulcerative colitis / Ustekinumab / vedolizumab /
Continúa
2023
Severe and refractory gastrointestinal toxicity due to immune checkpoint inhibitors: clinical experience in a tertiary referral hospital

https://pubmed.ncbi.nlm.nih.gov/37170542/

https://www.reed.es/ArticuloFicha.aspx?id=12705&hst=0&idR=125&tp=1

enterocolitis / gastritis / gma / immune checkpoint inhibitors / Infliximab / microscopic colitis / observational / Refractory patients / RETROSPECTIVE / steroids / study / ulcerative colitis / Ustekinumab / vedolizumab /
Continúa
2023
Adsorptive cytapheresis in ulcerative colitis: A non-pharmacological therapeutic approach revisited

https://pubmed.ncbi.nlm.nih.gov/37787399/

https://onlinelibrary.wiley.com/doi/10.1002/jca.22091

elderly / gma / high-risk patients / Loss of response / partial response / positionning / Safety / steroid dependent / ulcerative colitis /
Continúa
2023
A case report on cotrimoxazole-induced Sweet syndrome – a dermatological dilemma

https://journals.co.za/doi/abs/10.10520/ejc-mp_sapj_v90_n5_a12

cotrimoxazole / Dermatology / gma / neutrophil infiltration / neutrophilic dermatoses / steroid / Sweet's syndrome /
Continúa
2023
Cutaneous findings and treatments in deficiency of interleukin-36 receptor antagonist (DITRA): A review of the literature

https://pubmed.ncbi.nlm.nih.gov/37726967/

https://onlinelibrary.wiley.com/doi/full/10.1111/exd.14934

anti IL-17A / anti-il12/23 / autoinflammmatory / biologics / DITRA / extradermatological manifestations / generalized pustular psoriasis / gma / GMAs responders / il-36 / IL36RN / pediatric / rare /
Continúa
2023
Successful Use of Granulocyte and Monocyte Adsorptive Apheresis in a Patient with Post-COVID-19 Multisystem Inflammatory Syndrome in Adults

https://pubmed.ncbi.nlm.nih.gov/37316277/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518551/

Covid-19 / gma / immunoglobulin / MIS-A / Multisystem inflammatory syndrome / myocarditis / pericarditis / steroid /
Continúa
2023
Sarcopenia and treatment failure in inflammatory bowel disease: a systematic review and meta-analysis

https://online.reed.es/DOI/PDF/ArticuloDOI_9808.pdf

concomitant drugs / gma / IBD / Safety / surgery / treatment -resistant /
Continúa
2023
Intensive Frequent Granulocyte Adsorptive Apheresis Therapy for Acute Fulminant Ulcerative Colitis: Two Consecutive Case Reports

https://pubmed.ncbi.nlm.nih.gov/37719478/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503873/

Acute / case report / Clinical remission / daily sessions / fulminant / gma / intensive / rapid efficay / Refractory patients / ulcerative colitis /
Continúa

ContáctanosPara solicitar información adicional

Contáctanos